Počet záznamů: 1  

NAD-capping: a universal RNA modification in Mycobacteria, Archaea and Escherichia coli

  1. 1.
    SYSNO ASEP0544953
    Druh ASEPA - Abstrakt
    Zařazení RIVZáznam nebyl označen do RIV
    Zařazení RIVNení vybrán druh dokumentu
    NázevNAD-capping: a universal RNA modification in Mycobacteria, Archaea and Escherichia coli
    Tvůrce(i) Ruiz-Larrabeiti, Olatz (MBU-M) ORCID
    Benoni, Roberto (UOCHB-X)
    Zemlianski, V. (CZ)
    Hanišáková, N. (CZ)
    Suder, A. (PL)
    Schwarz, Marek (MBU-M) ORCID, RID
    Brezovská, Barbora (MBU-M)
    Svojanovská, Barbora (UOCHB-X)
    Vítězová, M. (CZ)
    Cahová, Hana (UOCHB-X) RID, ORCID
    Převorovský, M. (CZ)
    Krásný, Libor (MBU-M) RID, ORCID
    Zdroj.dok.FEBS Open Bio . - : Wiley - ISSN 2211-5463
    Roč. 11, Suppl 1 (2021), s. 18
    Poč.str.1 s.
    Forma vydáníTištěná - P
    AkceFEBS Congress, Molecules of Life: Towards New Horizons /45./
    Datum konání03.07.2021 - 08.07.2021
    Místo konáníonline
    Typ akceWRD
    Jazyk dok.eng - angličtina
    Země vyd.GB - Velká Británie
    Obor OECDBiochemistry and molecular biology
    Institucionální podporaUOCHB-X - RVO:61388963 ; MBU-M - RVO:61388971
    UT WOS000668898600046
    AnotaceThe 50end status is key to the life of a transcript. NAD+(nicoti-namide adenine dinucleotide) universal redox cofactor has beendetected covalently attached to the 5’-end of RNA in bacterial and eukaryotic cells, where RNA polymerase uses NAD+insteadof ATP to initiate transcription. This new RNA modification hasbeen termed NAD-capping. Until now, NAD-capping had notbeen investigated in the mycobacterial genus, which containsimportant pathogens. At the same time, the nature of NAD+cofactor and the discovery of NAD-capping in a widespreadvariety of organisms raised up the possibility that NAD-cappingmay be a universal RNA modification, a hypothesis thatremained unproven until now. Likewise, a cohesive view of thebiological role of NAD-cap and its effect on the transcript andthe cell is still being formed. Here we show that NAD-cappingexists in mycobacteria, and that mycobacterial NAD-RNAs aremRNAs involved in membrane and redox processes and somesmall RNAs (sRNAs), like the characterized Ms1 and rnpB. Wehave also analysed archaeal RNA by mass spectrometry and dis-covered NAD+covalently attached to it, proofing that NAD-cap-ping is universal to all domains of life. Finally, we have studiedthe biological role of NAD-cap in RNAI, the most abundantlymodified sRNA in Escherichia coli. We found that preventingNAD-capping on RNAI caused it to have a longer half-life, andchanged the balance between RNAI and its regulatory target,which affected the ability of the cell to exit LAG phase at highampicillin concentrations, as compared to the wild-type. In thistalk I will explain how our discoveries on NAD-capping inMycobacteria, Archaea and Escherichia coli correlate to previousfindings, and how they add to our knowledge on transcriptomicmodifications.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Rok sběru2022
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.